Cargando…

Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process

More than a decade ago, a formalized fellowship training program in medical device innovation, the first of its kind, was created at Stanford University. Now in its 15th year, the Stanford Biodesign Fellowship Program is a 10-month program whereby postgraduate students with a prior background in med...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Jonathan G., Kumar, Uday N., Azagury, Dan E., Brinton, Todd J., Yock, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113348/
https://www.ncbi.nlm.nih.gov/pubmed/30167537
http://dx.doi.org/10.1016/j.jacbts.2016.06.011
_version_ 1783350999414472704
author Schwartz, Jonathan G.
Kumar, Uday N.
Azagury, Dan E.
Brinton, Todd J.
Yock, Paul G.
author_facet Schwartz, Jonathan G.
Kumar, Uday N.
Azagury, Dan E.
Brinton, Todd J.
Yock, Paul G.
author_sort Schwartz, Jonathan G.
collection PubMed
description More than a decade ago, a formalized fellowship training program in medical device innovation, the first of its kind, was created at Stanford University. Now in its 15th year, the Stanford Biodesign Fellowship Program is a 10-month program whereby postgraduate students with a prior background in medicine, engineering, and/or business form interdisciplinary teams for an experiential process of identifying unmet clinical needs, inventing new solutions, and implementing these ideas (the 3 “I’s”). A key component of this structured process is focused attention on needs finding and characterization, which differs from the traditional “tech-push” model (i.e., technologies looking for problems to solve). Although the Stanford Biodesign process can be applied to a wide variety of clinical areas, cardiovascular medicine is particularly well suited, given the breadth of clinical presentations it touches and its history of innovation to solve important clinical problems. Physicians play a vital role in the process, especially for needs identification and characterization. This paper outlines the Stanford Biodesign process and presents an argument for its repeat applicability, discusses its relevance to physicians and to cardiologists in particular, and provides a case study of the process that resulted in a currently available cardiovascular medical technology that came directly from the Fellowship Program.
format Online
Article
Text
id pubmed-6113348
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61133482018-08-30 Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process Schwartz, Jonathan G. Kumar, Uday N. Azagury, Dan E. Brinton, Todd J. Yock, Paul G. JACC Basic Transl Sci TRANSLATIONAL PERSPECTIVE More than a decade ago, a formalized fellowship training program in medical device innovation, the first of its kind, was created at Stanford University. Now in its 15th year, the Stanford Biodesign Fellowship Program is a 10-month program whereby postgraduate students with a prior background in medicine, engineering, and/or business form interdisciplinary teams for an experiential process of identifying unmet clinical needs, inventing new solutions, and implementing these ideas (the 3 “I’s”). A key component of this structured process is focused attention on needs finding and characterization, which differs from the traditional “tech-push” model (i.e., technologies looking for problems to solve). Although the Stanford Biodesign process can be applied to a wide variety of clinical areas, cardiovascular medicine is particularly well suited, given the breadth of clinical presentations it touches and its history of innovation to solve important clinical problems. Physicians play a vital role in the process, especially for needs identification and characterization. This paper outlines the Stanford Biodesign process and presents an argument for its repeat applicability, discusses its relevance to physicians and to cardiologists in particular, and provides a case study of the process that resulted in a currently available cardiovascular medical technology that came directly from the Fellowship Program. Elsevier 2016-10-31 /pmc/articles/PMC6113348/ /pubmed/30167537 http://dx.doi.org/10.1016/j.jacbts.2016.06.011 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle TRANSLATIONAL PERSPECTIVE
Schwartz, Jonathan G.
Kumar, Uday N.
Azagury, Dan E.
Brinton, Todd J.
Yock, Paul G.
Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
title Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
title_full Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
title_fullStr Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
title_full_unstemmed Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
title_short Needs-Based Innovation in Cardiovascular Medicine: The Stanford Biodesign Process
title_sort needs-based innovation in cardiovascular medicine: the stanford biodesign process
topic TRANSLATIONAL PERSPECTIVE
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113348/
https://www.ncbi.nlm.nih.gov/pubmed/30167537
http://dx.doi.org/10.1016/j.jacbts.2016.06.011
work_keys_str_mv AT schwartzjonathang needsbasedinnovationincardiovascularmedicinethestanfordbiodesignprocess
AT kumarudayn needsbasedinnovationincardiovascularmedicinethestanfordbiodesignprocess
AT azagurydane needsbasedinnovationincardiovascularmedicinethestanfordbiodesignprocess
AT brintontoddj needsbasedinnovationincardiovascularmedicinethestanfordbiodesignprocess
AT yockpaulg needsbasedinnovationincardiovascularmedicinethestanfordbiodesignprocess